Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Analytical Toxicology|May 1, 1989
Pyrolysis and volatilization of cocaineB R Martin, L P Lue, J P Boni
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Cocaine inhalation in the rat: pharmacokinetics and cardiovascular responseJ P Boni, W H Barr, B R Martin
British Journal of Cancer|May 7, 2008
Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimusJ P Boni, C Leister, J Burns, et al.
Pharmacotherapy|July 1, 1997
The influence of bromfenac on the pharmacokinetics and pharmacodynamic responses to glyburide in diabetic subjectsJ P Boni, W H Cevallos, S DeCleene, et al.
The Annals of Pharmacotherapy|April 1, 1997
Effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteersJ P Boni, S A DeCleene, W H Cevallos, et al.
Clinical Therapeutics|November 24, 1999
Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritisJ P Boni, J M Korth-Bradley, P Martin, et al.
Clinical Pharmacology and Therapeutics|March 1, 1997
Bromfenac disposition in patients with impaired kidney functionJ C Ermer, J P Boni, W H Cevallos, et al.
Oncology Research|January 1, 1996
alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine AL M Greenberger, K I Collins, T Annable, et al.
Pageof 1